Regulation of SHIP2 function through plasma membrane interaction

Advances in Enzyme Regulation

Volumn 50, Issue 1, 2010, Pages 262-271

  Deneubourg, Laurence ^a   Vanderwinden, Jean Marie ^a   Erneux, Christophe ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; INPPL1 PROTEIN, HUMAN; PHOSPHATASE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL; ARTICLE; CELL CULTURE; CELL MEMBRANE; CELL STRAIN COS1; CERCOPITHECUS; CYTOLOGY; FIBROBLAST; GENETICS; HELA CELL; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL MEMBRANE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOSKELETAL PROTEINS; FIBROBLASTS; HELA CELLS; HUMANS; MICE; PHOSPHATIDYLINOSITOLS; PHOSPHORIC MONOESTER HYDROLASES;

EID: 77955291512     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2009.10.009     Document Type: Article

References (46)

1. Aoki K., Nakamura T., Inoue T., Meyer T., Matsuda M. An essential role for the SHIP2-dependent negative feedback loop in neuritogenesis of nerve growth factor-stimulated PC12 cells. J Cell Biol 2007, 177:817-827.
2. Backers K., Blero D., Paternotte N., Zhang J., Erneux C. The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases. Adv Enzyme Regul 2003, 43:15-28.
3. Batty I.H., van der K.J., Gray A., Telfer J.F., Dixon M.J., Downes C.P. The control of phosphatidylinositol 3,4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2. Biochem J 2007, 407:255-266.
4. Blero D., Payrastre B., Schurmans S., Erneux C. Phosphoinositide phosphatases in a network of signalling reactions. Pflugers Arch 2007, 455:31-44.
5. Blero D., Zhang J., Pesesse X., Payrastre B., Dumont J.E., Schurmans S., et al. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts. FEBS J 2005, 272:2512-2522.
6. Chalhoub N., Baker S.J. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 2009, 4:127-150.
7. Clement S., Krause U., Desmedt F., Tanti J.F., Behrends J., Pesesse X., et al. The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 2001, 409:92-97.
8. Deleris P., Bacqueville D., Gayral S., Carrez L., Salles J.P., Perret B., et al. SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles. J Biol Chem 2003, 278:38884-38891.
9. Dyson J.M., Kong A.M., Wiradjaja F., Astle M.V., Gurung R., Mitchell C.A. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2. Int J Biochem Cell Biol 2005, 37:2260-2265.
10. Gewinner C., Wang Z.C., Richardson A., Teruya-Feldstein J., Etemadmoghadam D., Bowtell D., et al. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Cancer Cell 2009, 16:115-125.
11. Giuriato S., Pesesse X., Bodin S., Sasaki T., Viala C., Marion E., et al. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels. Biochem J 2003, 376:199-207.
12. Helgason C.D., Damen J.E., Rosten P., Grewal R., Sorensen P., Chappel S.M., et al. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev 1998, 12:1610-1620.
13. Ishihara H., Sasaoka T., Hori H., Wada T., Hirai H., Haruta T., et al. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling. Biochem Biophys Res Commun 1999, 260:265-272.
14. Ivetac I., Gurung R., Hakim S., Horan K.A., Sheffield D.A., Binge L.C., et al. Regulation of PI(3)K/Akt signalling and cellular transformation by inositol polyphosphate 4-phosphatase-1. EMBO Rep 2009, 10:487-493.
15. Lee S.R., Yang K.S., Kwon J., Lee C., Jeong W., Rhee S.G. Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 2002, 277:20336-20342.
16. Leslie N.R., Bennett D., Lindsay Y.E., Stewart H., Gray A., Downes C.P. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J 2003, 22:5501-5510.
17. Leslie N.R., Downes C.P. PTEN function: how normal cells control it and tumour cells lose it. Biochem J 2004, 382:1-11.
18. Leslie N.R., Yang X., Downes C.P., Weijer C.J. PtdIns(3,4,5)P(3)-dependent and -independent roles for PTEN in the control of cell migration. Curr Biol 2007, 17:115-125.
19. Liu Q., Sasaki T., Kozieradzki I., Wakeham A., Itie A., Dumont D.J., et al. SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev 1999, 13:786-791.
20. Majerus P.W., York J.D. Phosphoinositide phosphatases and disease. J Lipid Res 2009, 50(Suppl.):S249-S254.
21. Mandl A., Sarkes D., Carricaburu V., Jung V., Rameh L. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN. Mol Cell Biol 2007, 27:8098-8112.
22. McCrea H.J., De Camilli P. Mutations in phosphoinositide metabolizing enzymes and human disease. Physiology (Bethesda) 2009, 24:8-16.
23. Muraille E., Pesesse X., Kuntz C., Erneux C. Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells. Biochem J 1999, 342(3):697-705.
24. Ooms L.M., Horan K.A., Rahman P., Seaton G., Gurung R., Kethesparan D.S., et al. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem J 2009, 419:29-49.
25. Paternotte N., Zhang J., Vandenbroere I., Backers K., Blero D., Kioka N., et al. SHIP2 interaction with the cytoskeletal protein Vinexin. FEBS J 2005, 272:6052-6066.
26. Pesesse X., Deleu S., De S.F., Drayer L., Erneux C. Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem Biophys Res Commun 1997, 239:697-700.
27. Pesesse X., Dewaste V., De S.F., Laffargue M., Giuriato S., Moreau C., et al. The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells. J Biol Chem 2001, 276:28348-28355.
28. Pesesse X., Moreau C., Drayer A.L., Woscholski R., Parker P., Erneux C. The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity. FEBS Lett 1998, 437:301-303.
29. Podsypanina K., Ellenson L.H., Nemes A., Gu J., Tamura M., Yamada K.M., et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A 1999, 96:1563-1568.
30. Prasad N., Topping R.S., Decker S.J. SH2-containing inositol 5'-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading. Mol Cell Biol 2001, 21:1416-1428.
31. Prasad N.K., Decker S.J. SH2-containing 5'-inositol phosphatase, SHIP2, regulates cytoskeleton organization and ligand-dependent down-regulation of the epidermal growth factor receptor. J Biol Chem 2005, 280:13129-13136.
32. Raaijmakers J.H., Deneubourg L., Rehmann H., de K.J., Zhang Z., Krugmann S., et al. The PI3K effector Arap3 interacts with the PI(3,4,5)P3 phosphatase SHIP2 in a SAM domain-dependent manner. Cell Signal 2007, 19:1249-1257.
33. Rahdar M., Inoue T., Meyer T., Zhang J., Vazquez F., Devreotes P.N. A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Proc Natl Acad Sci U S A 2009, 106:480-485.
34. Sanada F., Taniyama Y., Iekushi K., Azuma J., Okayama K., Kusunoki H., et al. Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells. Circ Res 2009.
35. Schurmans S., Carrio R., Behrends J., Pouillon V., Merino J., Clement S. The mouse SHIP2 (Inppl1) gene: complementary DNA, genomic structure, promoter analysis, and gene expression in the embryo and adult mouse. Genomics 1999, 62:260-271.
36. Shaw M., Cohen P., Alessi D.R. The activation of protein kinase B by H2O2 or heat shock is mediated by phosphoinositide 3-kinase and not by mitogen-activated protein kinase-activated protein kinase-2. Biochem J 1998, 336(1):241-246.
37. Steen H., Kuster B., Fernandez M., Pandey A., Mann M. Tyrosine phosphorylation mapping of the epidermal growth factor receptor signaling pathway. J Biol Chem 2002, 277:1031-1039.
38. Trotman L.C., Wang X., Alimonti A., Chen Z., Teruya-Feldstein J., Yang H., et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 2007, 128:141-156.
39. Vandenbroere I., Paternotte N., Dumont J.E., Erneux C., Pirson I. The c-Cbl-associated protein and c-Cbl are two new partners of the SH2-containing inositol polyphosphate 5-phosphatase SHIP2. Biochem Biophys Res Commun 2003, 300:494-500.
40. Vazquez F., Devreotes P. Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction. Cell Cycle 2006, 5:1523-1527.
41. Wang Y., Keogh R.J., Hunter M.G., Mitchell C.A., Frey R.S., Javaid K., et al. SHIP2 is recruited to the cell membrane upon macrophage colony-stimulating factor (M-CSF) stimulation and regulates M-CSF-induced signaling. J Immunol 2004, 173:6820-6830.
42. Xie J., Onnockx S., Vandenbroere I., Degraef C., Erneux C., Pirson I. The docking properties of SHIP2 influence both JIP1 tyrosine phosphorylation and JNK activity. Cell Signal 2008, 20:1432-1441.
43. Yogo K., Mizutamari M., Mishima K., Takenouchi H., Ishida-Kitagawa N., Sasaki T., et al. Src homology 2 (SH2)-containing 5'-inositol phosphatase localizes to podosomes, and the SH2 domain is implicated in the attenuation of bone resorption in osteoclasts. Endocrinology 2006, 147:3307-3317.
44. Yu J., Ryan D.G., Getsios S., Oliveira-Fernandes M., Fatima A., Lavker R.M. MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. Proc Natl Acad Sci U S A 2008, 105:19300-19305.
45. Zhang J., Liu Z., Rasschaert J., Blero D., Deneubourg L., Schurmans S., et al. SHIP2 controls PtdIns(3,4,5)P(3) levels and PKB activity in response to oxidative stress. Cell Signal 2007, 19:2194-2200.
46. Zhuang G., Hunter S., Hwang Y., Chen J. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via PI3 kinase-dependent Rac1 activation. J Biol Chem 2006, 282:2683-2694.